Skip to main content
SpringerLink
Log in

Mammakarzinom

  • Chapter
  • First Online:
Book cover Strahlentherapie

  • 9107 Accesses

Zusammenfassung

In den westlichen Industrieländern ist das Mammakarzinom die häufigste Tumorerkrankung der Frau, an der etwa jede Elfte erkrankt (Tab. 18.1).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 299.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  • Albain KS, Barlow WE, Ravdin PM, et al. (2009) Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trial. Lancet 374(9707):2055–2063

    PubMed  Google Scholar 

  • Anderson GL, Limacher M, Assaf AR, et al. (2004) Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women’s Health Initiative randomized controlled trial. JAMA 291(14):1701–1712

    PubMed  CAS  Google Scholar 

  • Antoniou A, Pharoah PDP, Narod S, et al. (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am. J. Hum. Genet; 72(5):1117–1130

    PubMed  CAS  Google Scholar 

  • Arriagada R, Lê MG, Rochard F, Contesso G. (1996) Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. Institut Gustave-Roussy Breast Cancer Group. J. Clin. Oncol 14(5):1558–1564

    CAS  Google Scholar 

  • Atkins HL, Horrigan WD (1961) Treatment of locally advanced carcinoma of the breast with roentgen therapy and simple mastectomy. AJR 85:865–869

    Google Scholar 

  • Bartelink H, Horiot J, Poortmans PM, et al. (2007) Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. J Clin Oncol 25(22):3259–3265

    PubMed  Google Scholar 

  • Bartelink H, Horiot JC, Poortmanns P et al. (2001) Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med 11;345(19):1378–1387

    PubMed  CAS  Google Scholar 

  • Bäsler R (1994) Pathologie des Mammakarzinoms. In: Klinische Onkologie 94/95. Schweizerische Rundschau für Medizin, Praxis Verlag Hallwag, S 216–233

    Google Scholar 

  • Baum M (2001) The ATAC (Arimidex, Tamoxifen, Alone or in Combination) adjuvant breast cancer trial in post-menopausal women. Breast Cancer Res Treat 69(3):Abstract 8

    Google Scholar 

  • Bayerl A, Frank D, Lenz A et al. (2001) Lokale Tumorkontrolle und kosmetisches Ergebnis nach brusterhaltender Operation und Strahlentherapie bis 56 Gy Gesamtdosis ohne Boost beim Mammakarzinom. Strahlenther Onkol 1:25–32

    Google Scholar 

  • Becker H, Chang-Claude J (1996) Estimating population-specific disease risks for a given family history with an application to breast cancer. Fenet Epidemiol 13:229–242

    Google Scholar 

  • Becker N, Junkermann H (2008) Betrachtungen aus epidemiologischer Sicht: Nutzen und Risiko des Mammografiescreenings. Dtsch Arztebl 105(8): 131–136

    Google Scholar 

  • Becker N, Wahrendorf J (1998) Krebsatlas der Bundesrepublik Deutschland 1981–1990. Springer, Berlin Heidelberg New York Tokio, S 366–370

    Google Scholar 

  • Beckham WA, Popescu CC, Patenaude VV, et al. (2007) Is multibeam IMRT better than standard treatment for patients with left-sided breast cancer? Int J Radiat Oncol Biol Phys 69:918–924

    PubMed  Google Scholar 

  • Bentzen SM, Agrawal RK, Aird EGA, et al. (2008) The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet 371(9618):1098–1107

    PubMed  CAS  Google Scholar 

  • Bentzen SM, Agrawal RK, Aird EGA, et al. (2008) The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol 2008;9(4):331–341

    PubMed  CAS  Google Scholar 

  • Beral V. (2003) Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 362(9382):419–427

    PubMed  CAS  Google Scholar 

  • Blichert-Toft M, Nielsen M, Düring M, et al. (2008) Long-term results of breast conserving surgery vs. mastectomy for early stage invasive breast cancer: 20-year follow-up of the Danish randomized DBCG-82TM protocol. Acta Oncol 47(4):672–681

    PubMed  Google Scholar 

  • Block G, Patterson B, Suber A (1992) Fruit, vegetables and cancer prevention: A review of the epidemiological evidence. Nutr Cancer 18:1–29

    PubMed  CAS  Google Scholar 

  • Bloom HJG, Richardson WW (1957) Histological grading and prognosis in breast cancer: A study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer 11:359–377

    PubMed  CAS  Google Scholar 

  • Boccardo F et al. (1999) LHRH-agonist (LHRH-A) + tamoxifen (TAM) versus LHRH-A alone in premenopausal women with advanced breast cancer (ABC): Results of a meta-analysis of four trials. Proc ASCO, abstract 416

    Google Scholar 

  • Boccardo F et al. (2001) Sequential Tamoxifen and Aminoglutethimide versus Tamoxifen alone in the adjuvant treatment of postmenopausal breast cancer patients: results of an Italian cooperative study. J Clin Oncol 19(22):4209–4215

    PubMed  CAS  Google Scholar 

  • Bonneterre J, Buzdar A, Nabholtz JM, et al. (2001) Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma. Cancer 92(9):2247–2258

    PubMed  CAS  Google Scholar 

  • Buttgereit U (1998) Lokalrezidivhäufigkeit des Mammacarcinoms bei brusterhaltender Operationstechnik und eingeschränktem Bestrahlungsvolumen. Inauguraldissertation der Medizin. Fakultät der Universität Freiburg

    Google Scholar 

  • Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N. Engl. J. Med.;348(17):1625–1638

    PubMed  Google Scholar 

  • Citron ML, Berry DA, Cirrincione C, et al. (2003) Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741. J. Clin. Oncol 21(8):1431–1439

    CAS  Google Scholar 

  • Clark RM, Whelan T, Levine M et al. (1996) Randomized clinical trial of breast irradiation following lumpectomy and axillar dissection for node-negative breast cancer: An update. J Natur Cancer Inst 88:1659–1664

    CAS  Google Scholar 

  • Clarke M, Collins R, Darby S, et al. (2005) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366(9503):2087–2106

    PubMed  CAS  Google Scholar 

  • Cobleigh MA, Vogel CL, Tripathy NJ et al. (1998) Efficacy and safety of Herceptin (Human Anti-HER-2 antibody) as a single agent in 222 women with HER-2 overexpression who relapsed following chemotherapy for metastatic breast cancer. Proc ASCO 17:97a

    Google Scholar 

  • Collaborative Group on Hormonal Factors in Breast Cancer (1996) Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53297 women with breast cancer and 100239 women without breast cancer from 54 epidemiological studies. Lancet 347:1713–1727

    Google Scholar 

  • Coombes RC, Kilburn LS, Snowdon CF, et al. (2007) Survival and safety of exemestane versus tamoxifen after 2-3 years’ tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial. Lancet 369(9561):559–570

    PubMed  CAS  Google Scholar 

  • Cuzick J, Stewart H, Rutquist L et al. (1994) Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. JCO 12:447–453

    CAS  Google Scholar 

  • Dunne C, Burke JP, Morrow M, Kell MR (2009) Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ. J. Clin. Oncol 27(10):1615–1620

    Google Scholar 

  • Dunst J, Eiermann W, Rauschecker HF, Winzer K-J, Wörrmann B (2002) Das lokale Rezidiv beim Mammakarzinom. Der Onkologe 8:867–873

    Google Scholar 

  • Early Breast Cancer Trialists Collaborative Group (1995) Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trails. New Engl J Med 333:1444–1455

    Google Scholar 

  • Eidtmann H, de Boer R, Bundred N, et al. (2010) Efficacy of zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: 36-month results of the ZO-FAST Study. Ann Oncol 21 (11):2188–2194

    PubMed  CAS  Google Scholar 

  • Ejlertsen B (1999) Comparable Effect of Ovarian Ablation (OA) and CMF Chemotherapy in Premenopausal Hormone Receptor Positive Breast Cancer Patients (PRP).ASCO Annual Meeting. Abstract 248

    Google Scholar 

  • Emdin SO, Granstrand B, Ringberg A, et al. (2006) SweDCIS: Radiotherapy after sector resection for ductal carcinoma in situ of the breast. Results of a randomised trial in a population offered mammography screening. Acta Oncol 45(5):536–543

    PubMed  Google Scholar 

  • Erren TC (2001) A meta-analysis of epidemiologic studies of electric and magnetic fields and breast cancer in women and men. Bioelectromagnetics Suppl. 5: S105–119

    Google Scholar 

  • Feyer P, Sautter-Bihl M, Budach W, et al. (2010) DEGRO Practical Guidelines for palliative radiotherapy of breast cancer patients: brain metastases and leptomeningeal carcinomatosis. Strahlenther Onkol 186(2):63–69

    PubMed  Google Scholar 

  • Fischer B, Redmond C, Fisher ER, Caplan R and other contributing NSABP investigators (1988) Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicator of prognosis in node negative breast cancer patients: Findings from National Surgical Adjuvant Breast and Bowel Project Protocol B06. J Clin Oncol 6:1076–1087

    Google Scholar 

  • Fisher B, Anderson S, Redmond CK, et al. (1995) Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 333(22):1456–1461

    PubMed  CAS  Google Scholar 

  • Fisher B, Bryant J, Dignam JJ, et al. Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. J Clin Oncol. 2002;20(20):4141–4149

    PubMed  CAS  Google Scholar 

  • Fisher B, Dignam J, Wolmark N et al. (1998) Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol 16:441–452

    PubMed  CAS  Google Scholar 

  • Fisher B, Dignam J, Wolmark N et al. (1999) Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomized controlled trial. Lancet 353:1993–2001

    PubMed  CAS  Google Scholar 

  • Fisher B, Jeong J-H, Anderson S, Bryant J, Fisher ER, Wolmark N (2002) Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. NEJM 347:567–575

    PubMed  Google Scholar 

  • Fletcher GH (1972) Local results of irradiation in the primary management of localized breast cancer. Cancer 29:549–551

    Google Scholar 

  • Floyd SR, Taghian AG (2009) Post-mastectomy radiation in large node-negative breast tumors: does size really matter? Radiother Oncol. 2009;91(1):33–37

    PubMed  Google Scholar 

  • Fowble B, Hanlon A, Freedmann G et al. (2000) Internal mammary node irradiation either decreases distant metastases nor improves survival in stage I and II breast cancer. Int J Radiat Oncol Biol Phys 47:883–894

    PubMed  CAS  Google Scholar 

  • Gerber B (2001) Einfluss von Umwelt, Ernährung und Lebensstil auf das Brustkrebsrisiko Dtsch Arztebl 98(24): A1612–1619

    Google Scholar 

  • Gnant M, Mlineritsch B, Schippinger W, et al. (2009) Endocrine therapy plus zoledronic acid in premenopausal breast cancer. N. Engl. J. Med 360(7):679–691

    PubMed  CAS  Google Scholar 

  • Gold HT, Do HT, Dick AW (2008) Correlates and effect of suboptimal radiotherapy in women with ductal carcinoma in situ or early invasive breast cancer. Cancer 113(11):3108–3115

    PubMed  Google Scholar 

  • Goldhirsch A, Ingle JN, Gelber RD, et al. (2009) Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer. Ann. Oncol;20(8):1319–1329

    PubMed  CAS  Google Scholar 

  • Goss PE, Ingle JN, Martino S, et al. (2005) Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17. J. Natl. Cancer Inst 97(17):1262–1271

    PubMed  CAS  Google Scholar 

  • Haffty B, Buchholz T, Perez C (2008) Breast Tumors: Early Stage Breast Cancer. In: Perez CA, Brady LW (Hrsg) Principles and practice of radiation oncology. 5. Auflage Lippincott, Philadelphia, pp 1175–1291

    Google Scholar 

  • Hammer J, Seewald DH, Track C et al. (1994) Breast cancer: primary treatment with external-beam radiation therapy and high-dose-rate iridium implantation. Radiology 193:573–577

    PubMed  CAS  Google Scholar 

  • Hammer J, Track C, Seewald DH, Spiegl K, Feichtinger J, Weis E (2002) 192-Ir HDR brachytherapy or electron beam boost or no boost in breast conserving therapy: a retrospective comparison. Strahlenther Oncol 178 (Sondernr. 1):3

    Google Scholar 

  • Harbeck N, Schmitt M, Meisner C, et al. (2009) Final 10-year analysis of prospective multicenter Chemo N0 trial for validation of ASCO-recommended biomarkers uPA/PAI-1 for therapy decision making in node-negative breast cancer. J Clin Oncol (Meeting Abstracts) 27(15S):511

    Google Scholar 

  • Harms W, Krempien R, Grehn C, Hensley F, Berns C, Wannemacher M (2003) Rebestrahlung der Thoraxwand bei lokal rezidivierenden Mammakarzinomen. Zentralbl Gynäkol

    Google Scholar 

  • Harms W, Krempien R, Hensley F, Berns C, Fritz P, Wannenmacher M (2002) 5-year results of pulsed dose rate brachytherapy applied as a boost after breast-conserving therapy in patients at high risk for local recurrence from breast cancer. Strahlenther Oncol 11:607–614

    Google Scholar 

  • Hennequin C, Durdux C, Espie M et al. (1999) High-dose-rate brachytherapy for early breast cancer: an ambulatory technique. Int J Radiat Oncol Biol Phys 45:85–90

    PubMed  CAS  Google Scholar 

  • Hoeller U, Borgmann K, Feyer P, Souchon R. (2007) On the interaction of adjuvant radiotherapy and tamoxifen treatment for breast cancer. Strahlenther Onkol 183(10):535–544

    PubMed  Google Scholar 

  • Höffken K (2002) Neue TNM-Klassifikation bei Brustkrebs. Onkologe 8:789

    Google Scholar 

  • Hofmann W, Schlag PM, Scherneck S (1998) Genetische Prädisposition beim Mammacarcinom. Onkologe 4:868–877

    Google Scholar 

  • Holland et al. (1985) Histologic multifocality of Tis, T1-2 breast carcinoma. Implications for clinical trials of breast-conserving surgery. Cancer 56 (5):979–990

    Google Scholar 

  • Holli K, Hietanen P, Saaristo R, et al. (2009) Radiotherapy after segmental resection of breast cancer with favorable prognostic features: 12-year follow-up results of a randomized trial. J. Clin. Oncol. 2009 27(6):927–932

    PubMed  Google Scholar 

  • Honrado E, Osorio A, Palacios J, Benitez J. (2006) Pathology and gene expression of hereditary breast tumors associated with BRCA1, BRCA2 and CHEK2 gene mutations. Oncogene;25(43):5837–5845

    PubMed  CAS  Google Scholar 

  • Honrado E, Osorio A, Palacios J, Benitez J. (2006) Pathology and gene expression of hereditary breast tumors associated with BRCA1, BRCA2 and CHEK2 gene mutations. Oncogene 25(43):5837–5845

    PubMed  CAS  Google Scholar 

  • Houghton J, George WD, Cuzick J, et al. (2003) Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial. Lancet 62(9378):95–102

    Google Scholar 

  • Howell A, Cuzick J, Baum M, et al. (2005) Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years’ adjuvant treatment for breast cancer. Lancet 365(9453):60–62

    PubMed  CAS  Google Scholar 

  • Jacobs H (1988) Experiences with interstitial HDR afterloading therapy in genital and breast cancer. Sonderb Strahlenther Onkol 82:266–270

    Google Scholar 

  • Jakesz R, Hausmaninger H, Kubista E, et al. (2002) Randomized adjuvant trial of tamoxifen and goserelin versus cyclophosphamide, methotrexate, and fluorouracil: evidence for the superiority of treatment with endocrine blockade in premenopausal patients with hormone-responsive breast cancer–Austrian Breast and Colorectal Cancer Study Group Trial 5. J. Clin. Oncol. 20(24):4621–4627

    PubMed  CAS  Google Scholar 

  • Jakesz R, Jonat W, Gnant M, et al. (2005) Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years’ adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial. Lancet 366(9484):455–462

    PubMed  CAS  Google Scholar 

  • Jatoi I, Proschan MA (2005) Randomized trials of breast-conserving therapy versus mastectomy for primary breast cancer: a pooled analysis of updated results. Am. J. Clin. Oncol. 28(3):289–294

    Google Scholar 

  • Jones HA, Antonini N, Hart AAM, et al. (2009) Impact of pathological characteristics on local relapse after breast-conserving therapy: a subgroup analysis of the EORTC boost versus no boost trial. J. Clin. Oncol. 27(30):4939–4947

    PubMed  Google Scholar 

  • Julien JP, Bijker N, Fentiman IS et al. (2000) Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomized phase III trial 10853. Lancet 355:528–533

    PubMed  CAS  Google Scholar 

  • Kaufmann M, Jonat W, v. Minckwitz G (2001) Aktuelle Empfehlung zur Therapie primärer Mammakarzinome. Dt Ärzteblatt 33:1839–1841

    Google Scholar 

  • Kohno N. (2008) Treatment of breast cancer with bone metastasis: bisphosphonate treatment - current and future. Int. J. Clin. Oncol. 13(1):18–23

    CAS  Google Scholar 

  • Konecny G, Pauletti G, Pegram M, et al. (2003) Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer. J. Natl. Cancer Inst 95(2):142–153

    CAS  Google Scholar 

  • Kreienberg R (2002) Mammakarzinom-Statements. Forum 1/02:36–41

    Google Scholar 

  • Kuhl C. (2007) The current status of breast MR imaging. Part I. Choice of technique, image interpretation, diagnostic accuracy, and transfer to clinical practice. Radiology 244(2):356–378

    PubMed  Google Scholar 

  • Kurtz J (2001) Which patients don’t need a tumor-bed boost after whole-breast radiotherapy? Strahlenther Onkol 177:33–36

    PubMed  CAS  Google Scholar 

  • Lancaster JM, Wooster R, Manjion J et al. (1996) BRCA2 mutations in primary breast and ovarian cancers. Nab Genet 13/2:238–240

    Google Scholar 

  • Lee SA, Ross RK, Pike MC. (2005) An overview of menopausal oestrogen-progestin hormone therapy and breast cancer risk. Br. J. Cancer. 92(11):2049–2058

    PubMed  CAS  Google Scholar 

  • Liljegren G, Holmberg L, Adami HO, et al. (1994) Sector resection with or without postoperative radiotherapy for stage I breast cancer: five-year results of a randomized trial. Uppsala-Orebro Breast Cancer Study Group. J. Natl. Cancer Inst. 86(9):717–722

    PubMed  CAS  Google Scholar 

  • Lind PA et al. (2002) Technical factors associated with radiation pneumonitis after local +/– regional radiation therapy for breast cancer. Int J Radiat Oncol Biol Phys 52(1): 137–143

    PubMed  Google Scholar 

  • Lohr F, Heggemann F, Papavassiliu T et al. (2009) Is cardiotoxicity still an issue after breast-conserving surgery and could it be reduced by multifield IMRT? Strahlenther Onkol

    Google Scholar 

  • Lohrisch C, Paltiel C, Gelmon K, et al. (2006) Impact on survival of time from definitive surgery to initiation of adjuvant chemotherapy for early-stage breast cancer. J. Clin. Oncol 24(30):4888–4894

    Google Scholar 

  • Look MP, van Putten WLJ, Duffy MJ, et al. (2002) Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients. J. Natl. Cancer Inst. 94(2):116–128

    PubMed  CAS  Google Scholar 

  • Loomis DP, Savitz DA, Ananth CV (1994) Breast cancer mortality among female electrical workers in the United States. J Natl Cancer Just 86/12:921–925

    Google Scholar 

  • Manning M, Arthur DW, Schmidt-Ullrich RK et al. (2000) Interstitial high-dose-rate brachytherapy boost: the feasibility and cosmetic outcome of a fractionated outpatient delivery scheme. Int J Radiat Oncol Biol Phys 48:1301–1306

    PubMed  CAS  Google Scholar 

  • Martin M, Pienkowski T, Mackey J, et al. (2005) Adjuvant docetaxel for node-positive breast cancer. N. Engl. J. Med. 352(22):2302–2313

    PubMed  CAS  Google Scholar 

  • Martín M, Rodríguez-Lescure A, Ruiz A, et al. (2008) Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by Paclitaxel for early breast cancer. J. Natl. Cancer Inst. 100(11):805–814

    PubMed  Google Scholar 

  • Matzinger O, Heimsoth I, Poortmans P, et al. (2010) Toxicity at three years with and without irradiation of the internal mammary and medial supraclavicular lymph node chain in stage I to III breast cancer (EORTC trial 22922/10925). Acta Oncol. 49(1):24–34

    PubMed  Google Scholar 

  • Mauriac L, Keshaviah A, Debled M, et al. (2007) Predictors of early relapse in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial. Ann. Oncol. 18(5):859–867

    PubMed  CAS  Google Scholar 

  • McGuire SE, Gonzalez-Angulo AM, Huang EH, et al. (2007) Postmastectomy radiation improves the outcome of patients with locally advanced breast cancer who achieve a pathologic complete response to neoadjuvant chemotherapy. Int. J. Radiat. Oncol. Biol. Phys. 68(4):1004–1009

    PubMed  Google Scholar 

  • Miller K, Wang M, Gralow J, et al. (2007) Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer. N. Engl. J. Med. 357(26):2666–2676

    PubMed  CAS  Google Scholar 

  • Müller RP (2002) Strahlentherapie des Mammakarzinoms. In: Kreienberg et al. (Hrsg) Management des Mammakarzinoms, 2. Aufl. Springer, Berlin Heidelberg New York Tokio, S 205–221

    Google Scholar 

  • National Cancer Institute (2013) Breast Cancertreatment (PDQ): Health professional version.http://www.cancer.gov/cancertopics/pdq/treatment/breast/healthprofessional. Zugegriffen:06. April 2013

  • Nielsen HM, Overgaard M, Grau C, Jensen AR, Overgaard J. (2006) Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 b and c randomized studies. J. Clin. Oncol. 24(15):2268–2275

    PubMed  Google Scholar 

  • Olivotto IA, Lesperance ML, Truong PT, et al. (2009) Intervals longer than 20 weeks from breast-conserving surgery to radiation therapy are associated with inferior outcome for women with early-stage breast cancer who are not receiving chemotherapy. J. Clin. Oncol. 27(1):16–23

    PubMed  Google Scholar 

  • Overgaard M, Nielsen HM, Overgaard J. (2007) Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials. Radiother Oncol. 82(3):247–53

    PubMed  Google Scholar 

  • Petrova-Schumann K, Lukas P (2002) Kosmetische Ergebnisse der brusterhaltenden Therapie des Mammakarzinoms nach postoperativer homogener Photonenbestrahlung mit 56 Gy. Strahlenther Oncol 178 (Sondernr. 1):4

    Google Scholar 

  • Poggi MM, Danforth DN, Sciuto LC, et al. (2003) Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute Randomized Trial. Cancer. 98(4):697–702

    PubMed  Google Scholar 

  • Polgár C, Fodor J, Major T, et al. (2007) Breast-conserving treatment with partial or whole breast irradiation for low-risk invasive breast carcinoma–5-year results of a randomized trial. Int. J. Radiat. Oncol. Biol. Phys. 69(3):694–702

    PubMed  Google Scholar 

  • Poortmans PM, Collette L, Horiot J, et al. (2009) Impact of the boost dose of 10 Gy versus 26 Gy in patients with early stage breast cancer after a microscopically incomplete lumpectomy: 10-year results of the randomised EORTC boost trial. Radiother Oncol. 90(1):80–85

    PubMed  Google Scholar 

  • Ragaz J, Olivotto IA, Spinelli JJ, et al. (2005) Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J. Natl. Cancer Inst. 97(2):116–126

    PubMed  Google Scholar 

  • Recht A, Gray R, Davidson NE et al. (1999) Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: experience of the Eastern Cooperative Oncology Group. J Clin Oncol 17:1689–1700

    PubMed  CAS  Google Scholar 

  • Reitsamer R, Sedlmayer F, Kopp M, et al. (2006) The Salzburg concept of intraoperative radiotherapy for breast cancer: results and considerations. Int. J. Cancer. 118(11):2882–2887

    PubMed  CAS  Google Scholar 

  • Reitsamer R, Sedlmayer F, Kopp M, et al. (2008) Concepts and techniques of intraoperative radiotherapy (IORT) for breast cancer. Breast Cancer. 15(1):40–46

    PubMed  Google Scholar 

  • Romestaing P, Lehingue Y, Carrie C et al. (1997) Role of 10 Gy boost in the conservative treatment of early breast cancer: Results of a randomized clinical trial, Lion/France. J Clin Oncol 15:963–968

    PubMed  CAS  Google Scholar 

  • Rosen PP, Groshen S, Sanjo PE, Kinne DW, Hellmann S (1989) A long-term follow-up study of survival in Stage I (T1 N0 M0) and Stage II (T1 N1 M0) breast carcinoma. J Clin Oncol 7:355–366

    PubMed  CAS  Google Scholar 

  • Rowell NP (2009) Radiotherapy to the chest wall following mastectomy for node-negative breast cancer: a systematic review. Radiother Oncol. 91(1):23–32

    PubMed  Google Scholar 

  • Roy I, Fortin A, Larochelle M (2001) The impact of skin washing with water and soap during breast irradiation: a randomized study. Radiother Oncol 58(3):333–339

    PubMed  CAS  Google Scholar 

  • Sack H, Thesen N (1996) Brustdrüse, In: Scherer E, Sack H (Hrsg) Strahlentherapie Radiologische Onkologie, Kap. 34. S 661–681

    Google Scholar 

  • Sanghani M, Balk EM, Cady B (2009) Impact of axillary lymph node dissection on breast cancer outcome in clinically node negative patients: a systematic review and meta-analysis. Cancer. 115(8):1613–1620

    PubMed  Google Scholar 

  • Sartor CI, Peterson BL, Woolf S, et al. (2005) Effect of addition of adjuvant paclitaxel on radiotherapy delivery and locoregional control of node-positive breast cancer: cancer and leukemia group B 9344. J. Clin. Oncol. 23(1):30–40

    PubMed  CAS  Google Scholar 

  • Sauer R (2000) Adjuvante Radiotherapie nach brusterhaltender Operation des Mammakarzinoms. Diagnostik und Therapie des Mammakarzinoms, State of the art. Zuckschwerd, München Bern Wien San Francisco, S 225–233

    Google Scholar 

  • Sautter-Bihl M, Budach W, Dunst J, et al. (2007) DEGRO practical guidelines for radiotherapy of breast cancer I: breast-conserving therapy. Strahlenther Onkol. 2007;183(12):661–666

    PubMed  Google Scholar 

  • Sautter-Bihl M, Hültenschmidt B, Melcher U, Ulmer U (2002) Radiotherapy of internal mammary lymph nodes in breast cancer. Strahlenther Oncol 1:18–24

    Google Scholar 

  • Sautter-Bihl M, Souchon R, Budach W, et al. (2008) DEGRO practical guidelines for radiotherapy of breast cancer II. Postmastectomy radiotherapy, irradiation of regional lymphatics, and treatment of locally advanced disease. Strahlenther Onkol. 184(7):347–53

    PubMed  Google Scholar 

  • Sayer HG, Claßen J, Budach W, Höffken K (2002) Therapie des metastasierten Mammakarzinoms. Onkologe 8:874–879

    Google Scholar 

  • Schreer J (1998) Früherkennung und Prognosefaktoren beim Mammakarzinom. Onkologe 10:902–913

    Google Scholar 

  • Shak S, Paton V, Bajamonde A et al. (1998) Addition of Herceptin (Humanized Anti HER2 Antibody) to first line chemotherapy for HER2 overexpressing metastatic breast cancer (HER2 + MBC) markedly increases anticancer activity: a randomized multinational controlled phase III trial. Proc, ASCO 17:98 a

    Google Scholar 

  • Sickles E (2000) Breast imaging: from 1965 to the present. Radiology 215:1–16

    PubMed  CAS  Google Scholar 

  • Silverstein MJ, Lagios MD, Groshen S et al. (1996) A prognostic index for ductal carcinoma in situ of the breast. Cancer 77:2267–2274

    PubMed  CAS  Google Scholar 

  • Silverstein MJ, Lagios MD, Groshen S et al. (1999) The influence of margin width on local control of ductal carcinoma in situ of the breast. NEJM 340:1455–1461

    PubMed  CAS  Google Scholar 

  • Silverstein MJ. T (2003) he University of Southern California/Van Nuys prognostic index for ductal carcinoma in situ of the breast. Am J Surg. 186(4):337–343

    Google Scholar 

  • Sinclair S, Swain SM. (2010) Primary systemic chemotherapy for inflammatory breast cancer. Cancer 116(11 Suppl):2821–2828

    PubMed  CAS  Google Scholar 

  • Smith I, Procter M, Gelber RD, et al. (2007) 2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial. Lancet. 369(9555):29–36

    PubMed  CAS  Google Scholar 

  • Smith-Warner SA, Spiegelman D, Yaun SS, et al. (1998) Alcohol and breast cancer in women: a pooled analysis of cohort studies. JAMA;279(7):535–540

    PubMed  CAS  Google Scholar 

  • Souchon R, Wenz F, Sedlmayer F, et al. (2009) DEGRO practice guidelines for palliative radiotherapy of metastatic breast cancer: bone metastases and metastatic spinal cord compression (MSCC). Strahlenther Onkol. 185(7):417–424

    PubMed  Google Scholar 

  • Straver ME, Meijnen P, van Tienhoven G, et al. (2010) Role of axillary clearance after a tumor-positive sentinel node in the administration of adjuvant therapy in early breast cancer. J. Clin. Oncol 28(5):731–737

    Google Scholar 

  • Straver ME, Meijnen P, van Tienhoven G, et al. (2010) Sentinel node identification rate and nodal involvement in the EORTC 10981-22023 AMAROS trial. Ann. Surg. Oncol. 17(7):1854–1861

    Google Scholar 

  • Strom EA, Woodward WA, Katz A, et al. (2005) Clinical investigation: regional nodal failure patterns in breast cancer patients treated with mastectomy without radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 63(5):1508–1513

    PubMed  Google Scholar 

  • Sze WM, Shelley MD, Held I, Wilt TJ, Mason MD (2003) Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy–a systematic review of randomised trials. Clin Oncol (R Coll Radiol) 15(6):345–352

    CAS  Google Scholar 

  • Tallet AV, Salem N, Moutardier V, et al. (2003) Radiotherapy and immediate two-stage breast reconstruction with a tissue expander and implant: complications and esthetic results. Int. J. Radiat. Oncol. Biol. Phys. 57(1):136–142

    PubMed  Google Scholar 

  • Thilmann C, Zabel A, Kuhn S et al. (2002) Invers geplante intensitätsmodulierte Strahlenbehandlung bei einer Patientin mit rechtsseitigem Mammakarzinom und Trichterbrust. Strahlenther Onkol 11:637–643

    Google Scholar 

  • Tjan-Heijnen VC, Pepels MJ, de Boer M, et al. (2009) Impact of omission of completion axillary lymph node dissection (cALND) or axillary radiotherapy (ax RT) in breast cancer patients with micrometastases (pN1mi) or isolated tumor cells (pN0[i+]) in the sentinel lymph node (SN): Results from the MIRROR study. J Clin Oncol (Meeting Abstracts). 27(18S):CRA506

    Google Scholar 

  • Toledano A, Garaud P, Serin D, et al. (2006) Concurrent administration of adjuvant chemotherapy and radiotherapy after breast-conserving surgery enhances late toxicities: long-term results of the ARCOSEIN multicenter randomized study. Int. J. Radiat. Oncol. Biol. Phys. 65(2):324–332

    PubMed  CAS  Google Scholar 

  • Tran NV, Chang DW et al. (2001) Comparison of immediate and delayed free TRAM flap breast reconstruction in patients receiving postmastectomy radiation therapy. Plast Reconstr Surg 108 (July):78–82

    PubMed  CAS  Google Scholar 

  • Truong PT, Jones SO, Kader HA, et al. (2009) Patients with t1 to t2 breast cancer with one to three positive nodes have higher local and regional recurrence risks compared with node-negative patients after breast-conserving surgery and whole-breast radiotherapy. Int J Radiat Oncol Biol Phys. 73(2):357–364

    PubMed  Google Scholar 

  • Unnithan J, Macklis R (2001) Contralateral breast cancer risk. Radiother Oncol 60:239–246

    PubMed  CAS  Google Scholar 

  • Untch M, de Waal JC, Dimpfl T et al. (2003) Klinik der In-situ-Karzinome. Manual Mammakarzinome, Tumorzentrum München. Zuckschwerdt, München

    Google Scholar 

  • Vaidya JS, Joseph DJ, Tobias JS, et al. (2010) Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial. Lancet 376(9735):91–102

    PubMed  Google Scholar 

  • van Dongen JA, Voogd AC, Fentiman IS, et al. (2009) Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J. Natl. Cancer Inst. 92(14):1143–1150

    Google Scholar 

  • Van Dyngen JA, Bartelink H, Fentismann JS et al. (1992) Factors influencing local relapse and survival and results of salonge treatment after breast conserving therapy in operable breast cancer: EORTC trial 10801, breast conservation compared with mastectomy in TMM stage and II breast cancer. Eur J Cancer 28A:801–805

    Google Scholar 

  • Veronesi U, Cascinelli N, Mariani L, et al. (2002) Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 347(16):1227–1232

    PubMed  Google Scholar 

  • Veronesi U, Marubini E, Mariani L, et al. (2001) Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial. Ann Oncol. 12(7):997–1003

    PubMed  CAS  Google Scholar 

  • Veronesi U, Paganelli G, Viale G, et al. (2003) A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N. Engl. J. Med. 349(6):546–553

    PubMed  Google Scholar 

  • Viani GA, Stefano EJ, Afonso SL, et al. (2007) Breast-conserving surgery with or without radiotherapy in women with ductal carcinoma in situ: a meta-analysis of randomized trials. Radiat Oncol. 2:28

    PubMed  Google Scholar 

  • Wahl AO, Rademaker A, Kiel KD, et al. (2008) Multi-institutional review of repeat irradiation of chest wall and breast for recurrent breast cancer. Int. J. Radiat. Oncol. Biol. Phys. 70(2):477–484

    PubMed  Google Scholar 

  • Wazer DE, Lowther D, Boyle T et al. (2001) Clinically evident fat necrosis in women treated with high-dose-rate brachytherapy alone for early stage breast cancer. Int J Radiat Oncol Biol Phys 50:107–111

    PubMed  CAS  Google Scholar 

  • Wenz F, Welzel G, Blank E, et al. (2010) Intraoperative Radiotherapy as a Boost During Breast-Conserving Surgery Using Low-Kilovoltage X-Rays: The First 5 Years of Experience With a Novel Approach. Int J Radiat Oncol Biol Phys. 77

    Google Scholar 

  • Whelan TJ, Pignol J, Levine MN, et al. (2010) Long-term results of hypofractionated radiation therapy for breast cancer. N. Engl. J. Med. 362(6):513–520

    PubMed  CAS  Google Scholar 

  • Winzer K, Sauer R, Sauerbrei W, et al. (2004) Radiation therapy after breast-conserving surgery; first results of a randomised clinical trial in patients with low risk of recurrence. Eur J Cancer 40 (7):998–1005

    PubMed  Google Scholar 

  • Wong JS, Kaelin CM, Troyan SL, et al. (2006) Prospective study of wide excision alone for ductal carcinoma in situ of the breast. J Clin Oncol. 24(7):1031–10366

    PubMed  Google Scholar 

  • Wong JS, O’Neill A, Recht A, Schnitt SJ, Connolly JL, Silver B, Harris JR (2000) The relationship between lymphatic vessel invasion, tumor size, and pathologic nodes status: can we predict who can avoid a third field in the absence of axillary dissection? Int J Radiat Oncol Biol Phys 48(1):133–137

    PubMed  CAS  Google Scholar 

  • Zavagno G, De Salvo GL, Scalco G, et al. (2008) A Randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella/GIVOM trial. Ann. Surg. 247(2):207–213

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Strahlentherapie Rhein/Pfalz, Stiftstr. 15, 67434, Neustadt, Deutschland

    H. Hof

  2. Radioonkologische Klinik, Klinikum Offenburg, Ebertplatz 12, 77654, Offenburg, Deutschland

    U. Freund

  3. Radioonkologie, St. Clara Spital, Kleinriechenstr. 30, 4016, Basel, Schweiz

    W. Harms

Authors
  1. H. Hof
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. U. Freund
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. W. Harms
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Universitätsklinikum Heidelberg, Heidelberg, Germany

    Michael Wannenmacher

  2. Universitätsklinikum Mannheim, Mannheim, Germany

    Frederik Wenz

  3. Universitätsklinikum Heidelberg, Heidelberg, Germany

    Jürgen Debus

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Hof, H., Freund, U., Harms, W. (2013). Mammakarzinom. In: Wannenmacher, M., Wenz, F., Debus, J. (eds) Strahlentherapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-88305-0_18

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-88305-0_18

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-88304-3

  • Online ISBN: 978-3-540-88305-0

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation